A Modified Laparoscopic Sleeve Gastrectomy for the Treatment of Type 2 Diabetes and Metabolic Syndrome in Obesity

    March 2012 in “ The American Journal of Surgery ”
    Eduardo Henrique Pirolla, Ricardo Jureidini, Mario L. Barbosa, Luis C. Ishikawa, Paulo Roberto Camargo
    TLDR Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.
    The study investigated the effects of modified laparoscopic sleeve gastrectomy (MLSG) on 150 individuals with type 2 diabetes and metabolic syndrome. After 24 months, 86.6% of patients achieved normal glycemic levels, with improved serum insulin and glycosylated hemoglobin levels, and all patients stopped using insulin, though 3 required oral hypoglycemics. The average weight loss was 44.6% for those with a BMI <45 kg/m² and 58% for those with a BMI >50 kg/m². Partial hair loss occurred in 14% of cases, linked to low serum zinc levels. The MLSG was deemed safe, with a low morbidity rate (2.7%) and no surgical mortality, effectively aiding in diabetes control and obesity treatment.
    Discuss this study in the Community →